dactinomycin has been researched along with gkt137831 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandes, RP; Chen, X; Devaraj, S; Jiang, JX; Page, P; Schröder, K; Serizawa, N; Szyndralewiez, C; Török, NJ | 1 |
1 other study(ies) available for dactinomycin and gkt137831
Article | Year |
---|---|
Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
Topics: Animals; Apoptosis; Bile Ducts; Dactinomycin; Fas Ligand Protein; Gene Deletion; Hepatic Stellate Cells; Hepatitis, Autoimmune; Hepatocytes; Humans; Ligation; Liver; Liver Cirrhosis; Mice; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; Pyrazoles; Pyrazolones; Pyridines; Pyridones; Rats; Reactive Oxygen Species; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta | 2012 |